// App-Quantinova.ai

833 : No detectable systemic absorption of topically applied 0.02% and 0.04% chlormethine (CL) gel in patients with mycosis-fungoides cutaneous T-cell lymphoma (MF-CTCL)

Researchers

Presenter

  • C. Querfeld

Principal Investigators

  • J. Scarisbrick

  • P. Quaglino

  • E. Papadavid

  • P. Ortiz Romero

Medical Centers

  • City of Hope, Duarte, California, United States

  • University of Birmingham, Birmingham, United Kingdom

  • University of Turin, Turin, Italy

  • Attikon University Hospital, Athens, Greece.

  • Universidad Complutense, University Hospital 12 de Octubre, Madrid, Spain

Locations

  • United States

  • United Kingdom

  • Italy

  • Greece

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Cutaneous T-cell lymphoma

  • Mycosis fungoides

  • T-cell lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Mechlorethamine Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved